Skip to main content
VCbacked
Log inGet Started

Atsena Therapeutics

Durham, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

$150.0M raised
Apr 2025
Series C
BiotechnologyHealth CareTherapeutics

Top Investors

Wellington ManagementLightstone VenturesOUP (Osage University Partners)Hatteras Venture PartnersAbingworth

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atsena Therapeutics

How much funding has Atsena Therapeutics raised?
Atsena Therapeutics has raised $150.0M in total funding. The most recent round was Series C. The last funding was announced in April 2025.
Who are Atsena Therapeutics's investors?
Atsena Therapeutics's investors include Wellington Management, Lightstone Ventures, OUP (Osage University Partners), Hatteras Venture Partners, Abingworth.
Where is Atsena Therapeutics headquartered?
Atsena Therapeutics is headquartered in Durham, United States.
What does Atsena Therapeutics do?
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
What stage is Atsena Therapeutics at?
Atsena Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Atsena Therapeutics — Funding & Investors." VCBacked, April 2, 2025, https://www.vcbacked.co/company/atsena-therapeutics. Accessed June 9, 2026.
APA
VCBacked. (2025). Atsena Therapeutics — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/atsena-therapeutics
Wikipedia (cite web)
{{cite web |title=Atsena Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atsena-therapeutics |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong